These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 3071810
1. The role of peroxisomes in glycerol ether lipid metabolism. Hajra AK, Horie S, Webber KO. Prog Clin Biol Res; 1988; 282():99-116. PubMed ID: 3071810 [Abstract] [Full Text] [Related]
2. Aberration in de novo ether lipid biosynthesis in peroxisomal disorders. van den Bosch H, Schalkwijk CG, Schrakamp G, Wanders RJ, Schutgens RB, Schram AW, Tager JM. Prog Clin Biol Res; 1988; 282():139-50. PubMed ID: 3071794 [Abstract] [Full Text] [Related]
3. Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes. Datta NS, Wilson GN, Hajra AK. N Engl J Med; 1984 Oct 25; 311(17):1080-3. PubMed ID: 6566965 [Abstract] [Full Text] [Related]
4. [The contribution of peroxisomes to lipid metabolism]. Kramar R. J Clin Chem Clin Biochem; 1986 Feb 25; 24(2):109-18. PubMed ID: 3711795 [Abstract] [Full Text] [Related]
5. [Peroxisomes and neurologic diseases]. Sereni C, Paturneau-Jouas M. Rev Neurol (Paris); 1989 Feb 25; 145(5):341-9. PubMed ID: 2472665 [Abstract] [Full Text] [Related]
7. Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. Schrakamp G, Schalkwijk CG, Schutgens RB, Wanders RJ, Tager JM, van den Bosch H. J Lipid Res; 1988 Mar 25; 29(3):325-34. PubMed ID: 3379344 [Abstract] [Full Text] [Related]
8. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. Wanders RJ, van Roermund CW, van Wijland MJ, Schutgens RB, Heikoop J, van den Bosch H, Schram AW, Tager JM. J Clin Invest; 1987 Dec 25; 80(6):1778-83. PubMed ID: 3680527 [Abstract] [Full Text] [Related]
9. Topography of ether phospholipid biosynthesis. Hardeman D, van den Bosch H. Biochim Biophys Acta; 1989 Nov 06; 1006(1):1-8. PubMed ID: 2804060 [Abstract] [Full Text] [Related]
10. Peroxisomal disorders: clinical commentary and future prospects. Wilson GN, Holmes RD, Hajra AK. Am J Med Genet; 1988 Jul 06; 30(3):771-92. PubMed ID: 2461077 [Abstract] [Full Text] [Related]
11. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders. Van Veldhoven PP. Verh K Acad Geneeskd Belg; 1998 Jul 06; 60(3):195-214. PubMed ID: 9803880 [Abstract] [Full Text] [Related]
12. Biogenesis of peroxisomes in fetal liver. Espeel M, Depreter M, Nardacci R, D'Herde K, Kerckaert I, Stefanini S, Roels F. Microsc Res Tech; 1997 Dec 01; 39(5):453-66. PubMed ID: 9408912 [Abstract] [Full Text] [Related]
18. Peroxisomal disorders in neurology. Wanders RJ, Heymans HS, Schutgens RB, Barth PG, van den Bosch H, Tager JM. J Neurol Sci; 1988 Dec 01; 88(1-3):1-39. PubMed ID: 3066850 [Abstract] [Full Text] [Related]
19. Differential deficiency of mevalonate kinase and phosphomevalonate kinase in patients with distinct defects in peroxisome biogenesis: evidence for a major role of peroxisomes in cholesterol biosynthesis. Wanders RJ, Romeijn GJ. Biochem Biophys Res Commun; 1998 Jun 29; 247(3):663-7. PubMed ID: 9647750 [Abstract] [Full Text] [Related]
20. Immunological analyses of alkyl-dihydroxyacetone-phosphate synthase in human peroxisomal disorders. Biermann J, Gootjes J, Humbel BM, Dansen TB, Wanders RJ, van den Bosch H. Eur J Cell Biol; 1999 May 29; 78(5):339-48. PubMed ID: 10384985 [Abstract] [Full Text] [Related] Page: [Next] [New Search]